Literature DB >> 14583563

Glucocorticoids in the treatment of early and late RA.

J W J Bijlsma1, M Boers, K G Saag, D E Furst.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14583563      PMCID： PMC1754359          DOI： 10.1136/ard.62.11.1033

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  43 in total

Review 1.  Ocular complications of topical, peri-ocular, and systemic corticosteroids.

Authors:  M C Carnahan; D A Goldstein
Journal:  Curr Opin Ophthalmol       Date:  2000-12       Impact factor: 3.761

2.  Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?.

Authors:  Theodore Pincus; Tuulikki Sokka; C Michael Stein
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

3.  Neuroendocrine immune mechanisms in rheumatic diseases.

Authors:  Johannes W J Bijlsma; Rainer H Straub; Alfonse T Masi; Robert G Lahita; Maurizio Cutolo
Journal:  Trends Immunol       Date:  2002-02       Impact factor: 16.687

4.  Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.

Authors:  F Buttgereit; J A P da Silva; M Boers; G-R Burmester; M Cutolo; J Jacobs; J Kirwan; L Köhler; P Van Riel; T Vischer; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

5.  COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.

Authors:  Robert B M Landewé; Maarten Boers; Arco C Verhoeven; Rene Westhovens; Mart A F J van de Laar; Harry M Markusse; J Christiaan van Denderen; Marie Louise Westedt; Andre J Peeters; Ben A C Dijkmans; Piet Jacobs; Annelies Boonen; Désirée M F M van der Heijde; Sjef van der Linden
Journal:  Arthritis Rheum       Date:  2002-02

6.  A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects.

Authors:  M Hansen; J Podenphant; A Florescu; M Stoltenberg; A Borch; E Kluger; S F Sørensen; T M Hansen
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 7.  Moderate-term, low-dose corticosteroids for rheumatoid arthritis.

Authors:  L A Criswell; K G Saag; K M Sems; V Welch; B Shea; G Wells; M E Suarez-Almazor
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; K E Lee; L G Danforth
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

9.  Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Amalia A van Everdingen; Johannes W G Jacobs; Dirk R Siewertsz Van Reesema; Johannes W J Bijlsma
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

10.  Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.

Authors:  Glenn Haugeberg; Ragnhild E Ørstavik; Till Uhlig; Jan A Falch; Johan I Halse; Tore K Kvien
Journal:  Arthritis Rheum       Date:  2002-07
View more
  25 in total

1.  Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis.

Authors:  Vivian K Kawai; Carlos G Grijalva; Patrick G Arbogast; Jeffrey R Curtis; Daniel H Solomon; Elizabeth Delzell; Lang Chen; Rita Ouellet-Hellstrom; Lisa Herrinton; Liyan Liu; Edward F Mitchel; C Michael Stein; Marie R Griffin
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-10       Impact factor: 4.794

Review 2.  [Current insights into the development of new glucocorticoid receptor ligands].

Authors:  F Buttgereit; I-H Song; R H Straub; G-R Burmester
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

3.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

4.  Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia.

Authors:  Carl J Hochhauser; Michael Lewis; Barton A Kamen; Peter D Cole
Journal:  Support Care Cancer       Date:  2005-09-28       Impact factor: 3.603

5.  Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.

Authors:  Carlos G Grijalva; Lang Chen; Elizabeth Delzell; John W Baddley; Timothy Beukelman; Kevin L Winthrop; Marie R Griffin; Lisa J Herrinton; Liyan Liu; Rita Ouellet-Hellstrom; Nivedita M Patkar; Daniel H Solomon; James D Lewis; Fenglong Xie; Kenneth G Saag; Jeffrey R Curtis
Journal:  JAMA       Date:  2011-11-06       Impact factor: 56.272

6.  Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.

Authors:  J Jacobs; L-A Korswagen; A M Schilder; L H van Tuyl; B A C Dijkmans; W F Lems; A E Voskuyl; I E M Bultink
Journal:  Osteoporos Int       Date:  2012-10-03       Impact factor: 4.507

7.  Depicting and comparing the time to normalize "erythrocyte sedimentation rate" following two combination therapies in rheumatoid arthritis patients: a randomized clinical trial.

Authors:  Sasan Fallahi; Abdolrahman Rostamian; Ali Khalvat; Zahra Khazaeipour; Fatemeh Shahbazi
Journal:  Caspian J Intern Med       Date:  2013

8.  Initiation of rheumatoid arthritis treatments and the risk of serious infections.

Authors:  Carlos G Grijalva; Lisa Kaltenbach; Patrick G Arbogast; Edward F Mitchel; Marie R Griffin
Journal:  Rheumatology (Oxford)       Date:  2009-11-11       Impact factor: 7.580

9.  The Development of Novel Therapies for Rheumatoid Arthritis.

Authors:  Ling-Dong Quan; Geoffrey M Thiele; Jun Tian; Dong Wang
Journal:  Expert Opin Ther Pat       Date:  2008-07       Impact factor: 6.674

10.  Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.

Authors:  Kristin Andreas; Thomas Häupl; Carsten Lübke; Jochen Ringe; Lars Morawietz; Anja Wachtel; Michael Sittinger; Christian Kaps
Journal:  Arthritis Res Ther       Date:  2009-02-03       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.